tickdelta
Sign in
Screener / SEC EDGAR /CIK 0000001800 /10-K filed Feb 20, 2026, compared with Feb 21, 2025 /Numbers from the XBRL of the 10-Ks
Health care peers:
AMGNMDTBMYPFEABTTMO
NYSE Health care · Pharmaceuticals

Abbott Laboratories ABT

ABT quote by TradingView

Abbott Laboratories is an Illinois corporation, incorporated in 1900. 10-K, Item 1

Employees
115,000
Headquarters
Abbott Park, IL
CEO
Robert B. Ford
Next results
around Jan 21, 2027
Compare with peers Embed

Where each dollar of revenue went, FY2025

Revenue of $44.3B through the costs to a net profit of $6.5B · income statement of the 10-K

18% operating margin
Revenue to Gross profit: $25.0BRevenue to Cost of revenue: $19.3BGross profit to Operating profit: $8.1BGross profit to Operating expenses: $17.0BOperating profit to Net profit: $6.5BOperating profit to Tax & other: $1.5BOperating expenses to R&D: $2.9BOperating expenses to Sales, admin & other: $14.0B Revenue: $44.3B REVENUE $44.3B +6% Y/Y Gross profit: $25.0B · 56% margin GROSS PROFIT $25.0B 56% margin Cost of revenue: $19.3B · 44% of revenue COST OF REVENUE $19.3B 44% of revenue Operating profit: $8.1B · 18% margin OPERATING PROFIT $8.1B 18% margin · +18% Y/Y Operating expenses: $17.0B · 38% of revenue OPERATING EXPENSES $17.0B 38% of revenue Net profit: $6.5B · 15% margin NET PROFIT $6.5B 15% margin · −51% Y/Y Tax & other: $1.5B · 3% of revenue TAX & OTHER $1.5B 3% of revenue R&D: $2.9B · 7% of revenue R&D $2.9B 7% of revenue Sales, admin & other: $14.0B · 32% of revenue SALES, ADMIN & OTHER $14.0B 32% of revenue
Gross profit $25.0B 56% margin
Operating profit $8.1B 18% margin · +18% Y/Y
Net profit $6.5B 15% margin · −51% Y/Y
The full income statement, year by year

ABT among Health care peers

Six ratios from the latest 10-K. Each corner is the share of 59 peers the company is above, not a score.

Compare
Revenue growth: 5.7%, above 36% of 59 peers (their median 7.2%) REVENUE GROWTH 5.7% · above 36% Gross margin: 56.9%, above 36% of 50 peers (their median 65.2%) GROSS MARGIN 56.9% · above 36% Operating margin: 13.8%, above 52% of 50 peers (their median 13.4%) OPERATING MARGIN 13.8% · above 52% Net margin: 9.7%, above 51% of 59 peers (their median 9.5%) NET MARGIN 9.7% · above 51% FCF margin: 14.0%, above 42% of 55 peers (their median 15.8%) FCF MARGIN 14.0% · above 42% Return on capital: 7.6%, above 32% of 41 peers (their median 9.2%) RETURN ON CAPITAL 7.6% · above 32%
ABT Peer median Below the median

What changed

5 new risk paragraphs. 10-K filed Feb 20, 2026 against Feb 21, 2025.

Risk factors
5 new paragraphs, nothing like them in the previous 10-K
10-K Item 1A
Accounting checks
11 other checks clear
10-K · XBRL
Insiders
No open-market buys in the last 90 days
Form 4
Filings
5 in the last 30 days
EDGAR

Each row opens the detail with the quote and the filing. A row is a change worth reading, not a verdict.

Accounting checks

11 checks on the latest 10-K. Checks, not verdicts.

How it works

0facts worth reading about all 11 checks found nothing to note

  • Receivables +14.5% vs revenue +5.7% (+8.8 pts)
  • Cash from operations $9.6B vs net income $6.5B (FY ending Dec 31, 2025)
  • Inventory +4.7% vs revenue +5.7% (-0.9 pts)
8 more checks with nothing to note
  • Same auditor in both 10-Ks: Ernst & Young LLP
  • No statement of substantial doubt about going concern
  • No 8-K item 4.02 in the last 2 years
  • No NT 10-K or NT 10-Q in the last 2 years
  • The same matters as last year: Income taxes – Unrecognized tax benefits
  • No sentence in the 10-K concludes that controls were not effective because of a material weakness
  • No 8-K item 2.06 in the last 2 years
  • No 8-K item 1.03 in the last 2 years

In their words

5 paragraphs in Risk Factors that were not in the 10-K filed Feb 21, 2025. Quoted as filed.

All 5 new paragraphs
  1. Item 1A · new paragraph · not in the 10-K filed Feb 21, 2025 10-K, ITEM 1A
    Changes in geopolitical and macroeconomic conditions could negatively affect Abbott’s business, financial condition, and results of operations. As a global healthcare company with sales outside of the U.S. making up approximately 61 percent of Abbott’s net sales in 2025, Abbott’s business is subject to geopolitical and macroeconomic…

New risk paragraphs, against peers

Latest 10-K of each, Health care companies closest in revenue

Paragraphs in Risk Factors with nothing like them in the company's 10-K the year before. A count of text, not of risk.

Financial performance

Last 4 fiscal years · 10-K XBRL

All years
MetricFY2022FY2023FY2024FY2025
Revenue$43.7B$40.1B$42.0B$44.3B
Net income$6.9B$5.7B$13.4B$6.5B
Operating cash flow$9.6B$7.3B$8.6B$9.6B
Free cash flow$7.8B$5.1B$6.4B$7.4B

Revenue, FY2016 to FY2025

Ten fiscal years, each from its own 10-K · XBRL · USD

$44.3B ▲ 5.7% in FY2025

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Every number, year by year

Recent filings

5 filings in the last 30 days · SEC EDGAR

All filings

About the company

Abbott Laboratories, Abbott Park, IL · from the 10-K filed Feb 20, 2026

Abbott Laboratories is an Illinois corporation, incorporated in 1900. Abbott’s* principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products. On November 19, 2025, Abbott entered into a definitive agreement to acquire Exact Sciences Corporation (Exact Sciences), which is expected to enable Abbott to enter the cancer diagnostics market. The acquisition is subject to customary closing conditions, including the approval of Exact Sciences shareholders and obtaining the required regulatory clearances.

Headquarters
Abbott Park, IL
Country
United States
Listed on
NYSE
Fiscal year ends
December 31
Last results
Oct 21, 2026
Incorporated in
IL

Employees, at the top of the page: "As of December 31, 2025, Abbott employed approximately 115,000 people, 69% of whom were employed outside of the U" (10-K). Address and exchange: SEC's company file.

Email alerts

Sources

The 10-K filed Feb 20, 2026 (open at SEC), compared with the 10-K filed Feb 21, 2025. Numbers from the XBRL of the 10-Ks; filings from SEC EDGAR.

Work with it: Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/ABT/export.csv") into a cell.